142 related articles for article (PubMed ID: 14579580)
1. Structural basis for the enzymatic resistance of the GM2 ganglioside.
Li YT; Li SC; Ishida H; Kiso M; Raimondi L; Bernardi A; Sonnino S
Methods Enzymol; 2003; 363():242-64. PubMed ID: 14579580
[No Abstract] [Full Text] [Related]
2. Structural basis for the resistance of Tay-Sachs ganglioside GM2 to enzymatic degradation.
Li YT; Li SC; Hasegawa A; Ishida H; Kiso M; Bernardi A; Brocca P; Raimondi L; Sonnino S
J Biol Chem; 1999 Apr; 274(15):10014-8. PubMed ID: 10187778
[TBL] [Abstract][Full Text] [Related]
3. Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility.
Li YT; Li SC; Kiso M; Ishida H; Mauri L; Raimondi L; Bernardi A; Sonnino S
Biochim Biophys Acta; 2008 Mar; 1780(3):353-61. PubMed ID: 17967427
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
Schwarzmann G; Wendeler M; Sandhoff K
Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
[TBL] [Abstract][Full Text] [Related]
5. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
[TBL] [Abstract][Full Text] [Related]
6. The enzyme-binding region of human GM2-activator protein.
Wendeler M; Werth N; Maier T; Schwarzmann G; Kolter T; Schoeniger M; Hoffmann D; Lemm T; Saenger W; Sandhoff K
FEBS J; 2006 Mar; 273(5):982-91. PubMed ID: 16478472
[TBL] [Abstract][Full Text] [Related]
7. Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization.
Wendeler M; Hoernschemeyer J; John M; Werth N; Schoeniger M; Lemm T; Hartmann R; Kessler H; Sandhoff K
Protein Expr Purif; 2004 Mar; 34(1):147-57. PubMed ID: 14766311
[TBL] [Abstract][Full Text] [Related]
8. GM2 ganglioside activator occurs in multiple forms.
Novak A; Lowden JA
Biochim Biophys Acta; 1994 Mar; 1199(2):209-14. PubMed ID: 8123670
[TBL] [Abstract][Full Text] [Related]
9. Interaction of GM2 activator protein with glycosphingolipids.
Hama Y; Li YT; Li SC
J Biol Chem; 1997 Jan; 272(5):2828-33. PubMed ID: 9006924
[TBL] [Abstract][Full Text] [Related]
10. A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells.
Stubbs KA; Macauley MS; Vocadlo DJ
Angew Chem Int Ed Engl; 2009; 48(7):1300-3. PubMed ID: 19130519
[TBL] [Abstract][Full Text] [Related]
11. Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A.
Yadao F; Hechtman P; Kaplan F
Biochim Biophys Acta; 1997 Jun; 1340(1):45-52. PubMed ID: 9217013
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the affinity of the G(M2) activator protein for glycolipids by a fluorescence dequenching assay.
Smiljanic-Georgijev N; Rigat B; Xie B; Wang W; Mahuran DJ
Biochim Biophys Acta; 1997 May; 1339(2):192-202. PubMed ID: 9187239
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis.
Martin DR; Cox NR; Morrison NE; Kennamer DM; Peck SL; Dodson AN; Gentry AS; Griffin B; Rolsma MD; Baker HJ
Acta Neuropathol; 2005 Nov; 110(5):443-50. PubMed ID: 16200419
[TBL] [Abstract][Full Text] [Related]
14. [GM2 ganglioside activator protein deficiency].
Inui K
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):400-2. PubMed ID: 9645092
[No Abstract] [Full Text] [Related]
15. Expression and specificity of human GM2 activator protein.
Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
[TBL] [Abstract][Full Text] [Related]
16. The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein.
Mahuran DJ
Biochim Biophys Acta; 1998 Jul; 1393(1):1-18. PubMed ID: 9714704
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis of conjugatable saccharidic moieties of GM2 and GM3 gangliosides by engineered E. coli.
Fort S; Birikaki L; Dubois MP; Antoine T; Samain E; Driguez H
Chem Commun (Camb); 2005 May; (20):2558-60. PubMed ID: 15900325
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of an activator protein for the hydrolysis of ganglioside GM2 from the roe of striped mullet (Mugil cephalus).
DeGasperi R; Li YT; Li SC
Biochem J; 1989 Jun; 260(3):777-83. PubMed ID: 2527497
[TBL] [Abstract][Full Text] [Related]
19. Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli.
Antoine T; Priem B; Heyraud A; Greffe L; Gilbert M; Wakarchuk WW; Lam JS; Samain E
Chembiochem; 2003 May; 4(5):406-12. PubMed ID: 12740812
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and enzymatic susceptibility of a series of novel GM2 analogs.
Fuse T; Ando H; Imamura A; Sawada N; Ishida H; Kiso M; Ando T; Li SC; Li YT
Glycoconj J; 2006 Jul; 23(5-6):329-43. PubMed ID: 16897176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
